New influenza A viruses emerge in humans from time to time, causing global pandemics.
The most recent influenza pandemic began in 2009 with the influenza A (H1N1) pdm09 …

Background In an influenza pandemic, the benefit of vaccines and antiviral medications will
be constrained by limitations on supplies and effectiveness. Non-pharmaceutical public …

When a novel influenza A virus with pandemic potential emerges, nonpharmaceutical
interventions (NPIs) often are the most readily available interventions to help slow …

There were 3 influenza pandemics in the 20th century, and there has been 1 so far in the
21st century. Local, national, and international health authorities regularly update their plans …

Abstract The World Health Organization's recommended pandemic influenza interventions,
based on limited data, vary by transmission pattern, pandemic phase, and illness severity …

In June 2006, the Centers for Disease Control and Prevention released a request for
applications to identify, improve, and evaluate the effectiveness of nonpharmaceutical …

Since global availability of vaccine and antiviral agents against influenza caused by novel
human subtypes is insufficient, the World Health Organization (WHO) recommends …

Influenza virus infections are believed to spread mostly by close contact in the community.
Social distancing measures are essential components of the public health response to …

Background With an influenza pandemic seemingly imminent, we constructed a model
simulating the spread of influenza within the community, in order to test the impact of various …

The goal of this review was to examine the effectiveness of personal protective measures in
preventing pandemic influenza transmission in human populations. We collected primary …